JWCA
ABBV icon

J.W. Cole Advisors’s AbbVie ABBV Stock Holding History

J.W. Cole Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6M Sell
73,916
-822
-1% -$177K 0.32% 52
2026
Q1 		$16.3M Sell
74,738
-762
-1% -$169K 0.55% 30
2025
Q4 		$15.8M Sell
75,500
-13,613
-15% -$3.1M 0.38% 41
2025
Q3 		$20.6M Buy
89,113
+446
+0.5% +$90.8K 0.39% 37
2025
Q2 		$16.5M Buy
88,667
+25,289
+40% +$4.7M 0.35% 47
2025
Q1 		$13.3M Buy
63,378
+24,061
+61% +$4.68M 0.41% 40
2024
Q4 		$6.99M Buy
39,317
+174
+0.4% +$32K 0.28% 67
2024
Q3 		$7.73M Buy
39,143
+2,278
+6% +$425K 0.32% 60
2024
Q2 		$6.32M Buy
36,865
+1,254
+4% +$208K 0.3% 64
2024
Q1 		$6.47M Buy
35,611
+2
+0% +$345 0.33% 64
2023
Q4 		$5.52M Buy
35,609
+13,028
+58% +$1.9M 0.32% 72
2023
Q3 		$3.37M Buy
22,581
+2,159
+11% +$317K 0.25% 97
2023
Q2 		$2.75M Sell
20,422
-1,000
-5% -$147K 0.2% 126
2023
Q1 		$3.41M Sell
21,422
-1,645
-7% -$251K 0.24% 103
2022
Q4 		$3.73M Buy
23,067
+396
+2% +$60.7K 0.29% 80
2022
Q3 		$3.04M Sell
22,671
-2,315
-9% -$332K 0.25% 97
2022
Q2 		$3.83M Sell
24,986
-12,419
-33% -$1.9M 0.31% 76
2022
Q1 		$6.06M Sell
37,405
-862
-2% -$125K 0.41% 49
2021
Q4 		$5.18M Buy
38,267
+728
+2% +$86K 0.34% 62
2021
Q3 		$4.05M Buy
37,539
+1,471
+4% +$168K 0.29% 60
2021
Q2 		$4.06M Buy
36,068
+2,381
+7% +$268K 0.32% 73
2021
Q1 		$3.65M Buy
33,687
+2,603
+8% +$278K 0.35% 62
2020
Q4 		$3.33M Sell
31,084
-24,971
-45% -$2.4M 0.35% 64
2020
Q3 		$4.91M Buy
56,055
+27,726
+98% +$2.61M 0.38% 64
2020
Q2 		$2.78M Buy
28,329
+22,207
+363% +$1.96M 0.42% 65
2020
Q1 		$466K Sell
6,122
-19,625
-76% -$1.67M 0.9% 34
2019
Q4 		$2.28M Buy
+25,747
New +$2.14M 0.29% 95

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

J.W. Cole Advisors's ABBV Position: Q2 2026 in Review

J.W. Cole Advisors reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $177K and leaving 73,916 shares worth $18.6M. The position accounts for 0.32% of the portfolio, ranked #52.

J.W. Cole Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $20.6M in Q3 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • J.W. Cole Advisors held 73,916 shares of AbbVie worth $18.6M as of Q2 2026.
  • J.W. Cole Advisors sold 822 AbbVie shares in Q2 2026, an estimated $177K.
  • AbbVie made up 0.32% of J.W. Cole Advisors's portfolio in Q2 2026, its #52 holding.
  • J.W. Cole Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • J.W. Cole Advisors's AbbVie position peaked at $20.6M in Q3 2025.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.